Related Experiment Video
Updated: May 25, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Myoglobin-associated acute kidney injury in the setting of ciprofloxacin administration
Qi Qian1, Samih H Nasr, Clement O Akogyeram
1Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. qian.qi@mayo.edu
Abstract:
Myoglobin-associated kidney injury typically is seen in severe rhabdomyolysis. Nontraumatic rhabdomyolysis may be triggered by direct drug toxicity, drug-drug interactions, and individual patient myopathic risk factors. We present a case of myoglobin-associated kidney failure in the setting of repeated ciprofloxacin administration in a lung transplant patient. Kidney biopsy was critical to establishing the diagnosis and avoiding future exposure.
Insights
Repeated ciprofloxacin can cause myoglobin-related kidney injury, even without rhabdomyolysis. Kidney biopsy confirmed the diagnosis in a lung transplant patient, preventing further drug exposure and kidney damage.
Area of Science:
- Nephrology
- Pharmacology
- Transplantation
Background:
- Myoglobin-associated kidney injury is a known complication of severe rhabdomyolysis.
- Nontraumatic rhabdomyolysis can result from drug toxicity, drug interactions, or patient-specific myopathic factors.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Inhibitors of Bacterial DNA Synthesis
